Home › All Companies › BEATW

HeartBeam, Inc. (BEATW)

AI-Powered SEC Filing Analysis

Insider Trading Filed: 2026-04-16

Key Insights

  • The reporting person, Tim Cruickshank, who is the CFO of HeartBeam, Inc., acquired 31,250 shares of the company's common stock at $0.8 per share in connection with the company's public offering.
  • The total number of shares beneficially owned by the reporting person, including previously vested RSUs, is 72,230 shares.
  • The reporting person's purchase of shares in the public offering suggests they have a positive outlook on the company's future performance.
Sentiment: Positive Significance: 5/10
View Original Filing →
Insider Trading Filed: 2026-04-16

Key Insights

  • Insider Willem Elfrink has purchased 187,500 shares of HeartBeam, Inc. (BEATW) at $0.80 per share, increasing his direct ownership to 538,667 shares.
  • The purchase was made in connection with the company's recent underwritten public offering, suggesting Elfrink's confidence in the company's future prospects.
  • Insider buying can be a positive signal for investors, as it may indicate the insider's belief that the stock is undervalued and has potential for future growth.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-04-16

Key Insights

  • Insider Michael R. Jaff purchased 31,250 shares of HeartBeam, Inc. (BEATW) at $0.80 per share, indicating a bullish sentiment on the company's prospects.
  • The purchase was made in connection with HeartBeam's underwritten public offering, which priced on April 14, 2026 and closed on April 16, 2026.
  • The shares are indirectly held by Jaff through the entity Open Book Healthcare, suggesting a long-term investment in the company.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-04-16

Key Insights

  • Insider Branislav Vajdic purchased 31,250 shares of HeartBeam, Inc. (BEATW) at $0.80 per share, indicating his confidence in the company's prospects.
  • The purchase was made in connection with HeartBeam's underwritten public offering, suggesting the company is accessing capital markets to fund its operations.
  • Insider ownership has increased to 909,914 shares, aligning Vajdic's interests with other shareholders.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-04-16

Key Insights

  • Richard Ferrari, a director of HeartBeam, Inc. (BEATW), purchased 62,500 shares of the company's common stock at $0.80 per share, increasing his direct beneficial ownership to 291,636 shares.
  • The purchase was made in connection with the company's underwritten public offering of 12,500,000 shares, which was priced on April 14, 2026 and closed on April 16, 2026.
  • Insider buying by a director can be viewed as a positive signal, as it suggests the director has confidence in the company's prospects and believes the stock is undervalued.
Sentiment: Positive Significance: 7/10
View Original Filing →
Insider Trading Filed: 2026-04-16

Key Insights

  • President Robert Paul Eno purchased 12,500 shares of HeartBeam, Inc. (BEATW) stock at $0.8 per share, indicating confidence in the company's future prospects.
  • The purchase was made in connection with the company's underwritten public offering, suggesting Eno's alignment with the capital raise and growth strategy.
  • Eno's total beneficial ownership of 36,742 shares, including 23,333 RSUs that have vested, represents a significant personal investment in the company.
Sentiment: Positive Significance: 7/10
View Original Filing →
Insider Trading Filed: 2026-04-16

Key Insights

  • Marga Ortigas-Wedekind, a director of HeartBeam, Inc., purchased 25,000 shares of the company's common stock at $0.80 per share as part of a public offering.
  • This direct purchase of shares by an insider suggests their confidence in the company's prospects and potential upside in the stock price.
  • The timing of the transaction, occurring close to the public offering, indicates Ortigas-Wedekind's belief in the company's growth and valuation.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-04-16

Key Insights

  • Insider Mark E. Strome has acquired 750,000 shares of HeartBeam, Inc. (BEATW) common stock, increasing his beneficial ownership to 3,650,000 shares.
  • The purchase was made in connection with the company's recent public offering, suggesting Strome's confidence in the company's prospects.
  • Insider buying can be a positive signal for investors, as it indicates the belief of a key stakeholder in the company's future growth potential.
Sentiment: Positive Significance: 7/10
View Original Filing →
Current Report Filed: 2026-04-16

Key Insights

  • HeartBeam, Inc. conducted an underwritten public offering of 12.5 million shares of common stock at $0.80 per share, raising approximately $10 million in gross proceeds.
  • The company plans to use the net proceeds from the offering to support commercialization of its FDA-cleared 12-lead synthesized ECG system, advance development of its 12-lead ECG extended-wear patch and heart attack detection initiatives, and enhance its AI capabilities.
  • As part of the offering, the company granted the underwriter a 30-day option to purchase up to an additional 1.875 million shares to cover over-allotments, and issued warrants to the underwriter to purchase shares equal to 5% of the total shares sold.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • Marga Ortigas-Wedekind, a director of HeartBeam, Inc., has been granted 44,827 options to purchase common stock of the company, vesting over the next 6 months.
  • The options were granted on February 9, 2026 as part of the company's 2022 Equity Incentive Plan.
  • This insider buying activity suggests Ortigas-Wedekind's confidence in the company's future prospects.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • Richard Ferrari, a director of HeartBeam, Inc., acquired 50,000 shares of common stock at $0 per share on February 9, 2026, increasing his direct beneficial ownership to 229,136 shares.
  • The granted restricted stock units (RSUs) have a vesting schedule, with one half vesting on March 31, 2026 and the remaining half vesting on June 30, 2026.
  • This insider buying activity may signal Ferrari's confidence in the company's future prospects and could be seen as a positive signal for investors.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • The reporting person, Mark E. Strome, has been granted 41,380 options to purchase common stock of HeartBeam, Inc. (BEATW) on February 9, 2026, with half of the shares vesting on March 31, 2026 and the remaining half vesting on June 30, 2026.
  • This insider transaction indicates that the reporting person, who is a director of the company, has a long-term interest in the success of HeartBeam, Inc. and believes in the company's future prospects.
  • The vesting schedule of the options suggests that the company is providing incentives to its directors to align their interests with those of shareholders over the next several months.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • Michael R. Jaff, a director of HeartBeam, Inc. (BEATW), acquired 20,689 shares of the company's common stock on February 9, 2026. This insider buying activity suggests Jaff's confidence in the company's prospects.
  • The acquired shares are restricted stock units (RSUs) that will vest in two tranches - 50% on March 31, 2026 and the remaining 50% on June 30, 2026. This vesting schedule indicates a long-term investment horizon.
  • The RSUs were issued from the company's 2022 Equity Incentive Plan, which aligns management's interests with those of shareholders.
Sentiment: Positive Significance: 7/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • The reporting person, Branislav Vajdic, is the President and a Director of HeartBeam, Inc., indicating his significant role within the company.
  • Vajdic was granted 61,932 options to purchase common stock of the company, with half of the shares vesting in March 2026 and the remaining half vesting in June 2026.
  • The options were granted at an exercise price of $1.45 per share, which could suggest the company is seeking to incentivize Vajdic's continued leadership and performance.
Sentiment: Positive Significance: 7/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • Insider Tim Cruickshank, the CFO of HeartBeam, Inc. (BEATW), has been granted 53,104 stock options with an exercise price of $1.45 and a vesting schedule over the next 6 months.
  • The options are being issued from the company's 2022 Equity Incentive Plan, indicating continued executive compensation and alignment with shareholder interests.
  • The timing of the option grant, on February 9, 2026, suggests the company may be preparing for a significant corporate event or development in the near future.
Sentiment: Positive Significance: 7/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • Willem Elfrink, a director of HeartBeam, Inc. (BEATW), was granted 51,724 stock options on February 9, 2026 with a strike price of $1.43 and a vesting period ending on June 30, 2026.
  • This insider stock option grant suggests that Elfrink has a positive long-term outlook on the company and is aligning his interests with shareholders.
  • The timing and size of the option grant is notable, as it occurred within the past few months and represents a sizable position for the director.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • Insider Kenneth Warwick Nelson III acquired 17,241 shares of HeartBeam, Inc. (BEATW) on 02/09/2026 through restricted stock units (RSUs) granted by the company, increasing his direct beneficial ownership to 144,388 shares.
  • The RSUs granted to Nelson vest in two equal tranches, with 50% vesting on 03/31/2026 and the remaining 50% vesting on 06/30/2026, indicating the company's intent to incentivize and retain the director.
  • The RSU grant to the director is a common form of equity-based compensation, aligning his interests with those of other shareholders and providing an incentive for long-term value creation.
Sentiment: Positive Significance: 5/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • The reporting person, George de Urioste, was granted 51,724 stock options on February 9, 2026 from the company's 2022 Equity Incentive Plan, with half of the options vesting on March 31, 2026 and the remaining half vesting on June 30, 2026.
  • The granting of these options represents an insider transaction, which can provide insight into management's confidence in the company's future prospects.
  • The vesting schedule of the options, with a split between 3-month and 6-month periods, suggests the company may be incentivizing the director to remain engaged with the business in the near-to-medium term.
Sentiment: Positive Significance: 6/10
View Original Filing →
Insider Trading Filed: 2026-03-23

Key Insights

  • The reporting person, Robert Paul Eno, was granted 55,172 options to purchase common stock of HeartBeam, Inc. (BEATW) on February 9, 2026, with half of the options vesting on March 31, 2026 and the remaining half vesting on June 30, 2026.
  • The options were issued under the company's 2022 Equity Incentive Plan, which suggests the company is incentivizing its president to align his interests with shareholders.
  • The significant number of options granted to the president indicates the company's confidence in his leadership and the potential for the company's growth.
Sentiment: Positive Significance: 7/10
View Original Filing →
Annual Report Filed: 2026-03-12

Key Insights

  • The company filed an S-1 registration statement for a public stock offering, indicating it is seeking to raise additional capital to fund operations and growth initiatives.
  • The company has a new 2022 Equity Plan in place, which provides for the issuance of stock options and restricted stock units to executives and employees, aligning their interests with shareholders.
  • The company has entered into several private placement agreements, suggesting it is actively pursuing both public and private financing to support its business objectives.
Sentiment: Positive Significance: 7/10
View Original Filing →

Get real-time filing analysis in the app

Download on the App Store

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.